Overview

VolulyteTM in Cardiac Surgery

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The study will compare the efficacy and safety of VolulyteTM and human albumin in elective open-heart surgery in adult patients.
Phase:
Phase 4
Details
Lead Sponsor:
Fresenius Kabi
Treatments:
Hydroxyethyl Starch Derivatives
Pharmaceutical Solutions